Loading asset research
Q3 2026 earnings · Oct 27
Arcutis Biotherapeutics Inc. Common Stock
ARQTNasdaq · USD · StocksQuote as of · Exchange session not verified$23.89
+2.18%
Today
ARQT
Loading 1D prices…
Market cap
$3B
Volume
2M
52w high
$31.7752w low
$16.57Company profile
Arcutis Biotherapeutics Inc. Common Stock
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Westlake Village, CA, United States
Employees
354
Fiscal year end
1231
CIK
1787306
Session & valuation
Open$23.63
Previous close$23.38
Day high$24.18
Day low$23.55
30-day avg. volume1.9M
Outstanding shares125.7M
Diluted EPS-$0.13
Latest annual period
P/E (trailing)108.57
P/E (forward)18.33
Price / book13.60
Beta1.50
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| QUREuniQure N.V. Ordinary Shares | $3.1B | $16.1M | -1236.18% | -$3.46 | +0.07% | Buy |
| RCUSArcus Biosciences Inc. Common Stock | $3.1B | $33M | -1069.70% | -$3.29 | -6.04% | Buy |
| MBXMBX Biosciences Inc. Common Stock | $2.8B | $0.00 | — | -$2.38 | -3.23% | Buy |
| IMNMImmunome Inc. Common Stock | $2.8B | $6.9M | -3059.99% | -$2.43 | -1.20% | Buy |
| GPCRStructure Therapeutics Inc. American Depositary Shares | $2.8B | $0.00 | — | -$0.80 | -2.38% | Buy |